Clinical value at baseline and follow-up of myeloperoxidase-antibodies in ANCA-associated vasculitis
Regardless of AAV subtype, an increase in MPO-ANCA levels was associated with clinical deterioration. This study suggests that monitoring MPO-ANCA levels in AAV patients in remission could help clinicians to tailor therapy more effectively.
Authors
- B. Vokaer
- Julie Smet (ORCID: https://orcid.org/0000-0003-0325-4631)
- Elie Cogan (ORCID: https://orcid.org/0000-0003-2890-766X)
- Florence Roufosse (ORCID: https://orcid.org/0000-0002-5288-0375)
- Frédéric Vandergheynst (ORCID: https://orcid.org/0000-0002-1388-9262)
- Gabriel Bossan (ORCID: https://orcid.org/0009-0006-7511-9147)
Institutions
- Université Libre de Bruxelles (BE)
- Centre Hospitalier Interrégional Edith Cavell (BE)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.3389/fimmu.2025.1649708
- Citations
- 1
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.52